Interferon-free therapies for chronic hepatitis C: toward a hepatitis C virus-free world?
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interferon-free therapies for chronic hepatitis C: toward a hepatitis C virus-free world?
Authors
Keywords
-
Journal
Expert Review of Anti-Infective Therapy
Volume 12, Issue 7, Pages 763-773
Publisher
Informa UK Limited
Online
2014-06-11
DOI
10.1586/14787210.2014.929497
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Daclatasvir: The First of a New Class of Drugs Targeted Against Hepatitis C Virus NS5A
- (2014) I. Gentile et al. CURRENT MEDICINAL CHEMISTRY
- Ledipasvir: a novel synthetic antiviral for the treatment of HCV infection
- (2014) Ivan Gentile et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Investigational nucleoside and nucleotide polymerase inhibitors and their use in treating hepatitis C virus
- (2014) Ivan Gentile et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- MK-5172: a second-generation protease inhibitor for the treatment of hepatitis C virus infection
- (2014) Ivan Gentile et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Prevention of mother-to-child transmission of hepatitis B virus and hepatitis C virus
- (2014) Ivan Gentile et al. Expert Review of Anti-Infective Therapy
- O10 SAFETY AND EFFICACY OF THE ALL-ORAL REGIMEN OF MK-5172/MK-8742 ± RIBAVIRIN IN TREATMENT-NAIVE, NON-CIRRHOTIC, PATIENTS WITH HEPATITIS C VIRUS GENOTYPE 1 INFECTION: THE C-WORTHY STUDY
- (2014) C. Hezode et al. JOURNAL OF HEPATOLOGY
- O166 ALL-ORAL DUAL THERAPY WITH DACLATASVIR AND ASUNAPREVIR IN PATIENTS WITH HCV GENOTYPE 1B INFECTION: PHASE 3 STUDY RESULTS
- (2014) M. Manns et al. JOURNAL OF HEPATOLOGY
- O14 USE OF SOFOSBUVIR/LEDIPASVIR FIXED DOSE COMBINATION FOR TREATMENT OF HCV GENOTYPE-1 IN PATIENTS COINFECTED WITH HIV
- (2014) A. Osinusi et al. JOURNAL OF HEPATOLOGY
- O68 SOFOSBUVIR AND RIBAVIRIN FOR THE TREATMENT OF CHRONIC HCV WITH CIRRHOSIS AND PORTAL HYPERTENSION WITH AND WITHOUT DECOMPENSATION: EARLY VIROLOGIC RESPONSE AND SAFETY
- (2014) N. Afdhal et al. JOURNAL OF HEPATOLOGY
- O165 SIMEPREVIR PLUS SOFOSBUVIR WITH/WITHOUT RIBAVIRIN IN HCV GENOTYPE 1 PRIOR NULL-RESPONDER/TREATMENT-NAIVE PATIENTS (COSMOS STUDY): PRIMARY ENDPOINT (SVR12) RESULTS IN PATIENTS WITH METAVIR F3–4 (COHORT 2)
- (2014) E. Lawitz et al. JOURNAL OF HEPATOLOGY
- Retreatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin
- (2014) Stefan Zeuzem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin
- (2014) Jordan J. Feld et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection
- (2014) Nezam Afdhal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection
- (2014) Nezam Afdhal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis
- (2014) Kris V. Kowdley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase 2b Trial of Interferon-free Therapy for Hepatitis C Virus Genotype 1
- (2014) Kris V. Kowdley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Peg-Interferon Plus Ribavirin with or without Boceprevir or Telaprevir for HCV Genotype 1: A Meta-Analysis on the Role of Response Predictors
- (2014) Nicola Coppola et al. PLoS One
- Novel Therapeutic Approaches for Hepatitis C
- (2013) J S Au et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- A Novel Promising Therapeutic Option Against Hepatitis C Virus: An Oral Nucleotide NS5B Polymerase Inhibitor Sofosbuvir
- (2013) I. Gentile et al. CURRENT MEDICINAL CHEMISTRY
- Role of interleukin 28-B in the spontaneous and treatment-related clearance of HCV infection in patients with chronic HBV/HCV dual infection
- (2013) N. Coppola et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Erectile dysfunction in patients with chronic viral hepatitis: a systematic review of the literature
- (2013) Ferdinando Fusco et al. EXPERT OPINION ON PHARMACOTHERAPY
- Simeprevir for the treatment of chronic hepatitis C
- (2013) David M You et al. EXPERT OPINION ON PHARMACOTHERAPY
- Earlier Sustained Virologic Response End Points for Regulatory Approval and Dose Selection of Hepatitis C Therapies
- (2013) Jianmeng Chen et al. GASTROENTEROLOGY
- Efficacy of an Interferon- and Ribavirin-Free Regimen of Daclatasvir, Asunaprevir, and BMS-791325 in Treatment-Naive Patients With HCV Genotype 1 Infection
- (2013) Gregory T. Everson et al. GASTROENTEROLOGY
- A Simple Noninvasive Score Based on Routine Parameters can Predict Liver Cirrhosis in Patients With Chronic Hepatitis C
- (2013) Ivan Gentile et al. Hepatitis Monthly
- Association of tattooing and hepatitis C virus infection: A multicenter case-control study
- (2013) Kerrilynn Carney et al. HEPATOLOGY
- Randomized trial of daclatasvir and asunaprevir with or without PegIFN/RBV for hepatitis C virus genotype 1 null responders
- (2013) Anna S. Lok et al. JOURNAL OF HEPATOLOGY
- Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
- (2013) Troels K H Scheel et al. NATURE MEDICINE
- All-oral HCV therapies near approval
- (2013) Man Tsuey Tse NATURE REVIEWS DRUG DISCOVERY
- Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
- (2013) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
- (2013) Eric Lawitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sustained virological response: A milestone in the treatment of chronic hepatitis C
- (2013) Filomena Morisco WORLD JOURNAL OF GASTROENTEROLOGY
- Preclinical Characterization of GS-9669, a Thumb Site II Inhibitor of the Hepatitis C Virus NS5B Polymerase
- (2012) M. Fenaux et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Natural history of acute and chronic hepatitis C
- (2012) Benjamin Maasoumy et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Hepatitis C virus infection in an endemic area of Southern Italy 14 years later: Evidence for a vanishing infection
- (2012) Vincenzo Guadagnino et al. DIGESTIVE AND LIVER DISEASE
- Antiviral strategies in hepatitis C virus infection
- (2012) Christoph Sarrazin et al. JOURNAL OF HEPATOLOGY
- Dual oral therapy with daclatasvir and asunaprevir for patients with HCV genotype 1b infection and limited treatment options
- (2012) Yoshiyuki Suzuki et al. JOURNAL OF HEPATOLOGY
- Perspectives and challenges of interferon-free therapy for chronic hepatitis C
- (2012) Christian M. Lange et al. JOURNAL OF HEPATOLOGY
- miR-133a mediates TGF-β-dependent derepression of collagen synthesis in hepatic stellate cells during liver fibrosis
- (2012) Christoph Roderburg et al. JOURNAL OF HEPATOLOGY
- Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype 1
- (2012) Anna S. Lok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vitamin D improves viral response in hepatitis C genotype 2-3 naïve patients
- (2012) Assy Nimer WORLD JOURNAL OF GASTROENTEROLOGY
- Hepatitis B in pregnancy
- (2012) Guglielmo Borgia WORLD JOURNAL OF GASTROENTEROLOGY
- An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases
- (2011) Marc G. Ghany et al. HEPATOLOGY
- Vitamin D supplementation improves sustained virologic response in chronic hepatitis C (genotype 1)-naïve patients
- (2011) Saif Abu-Mouch WORLD JOURNAL OF GASTROENTEROLOGY
- Evolving epidemiology of hepatitis C virus
- (2010) D. Lavanchy CLINICAL MICROBIOLOGY AND INFECTION
- Surrogate endpoints and non-inferiority trials in chronic viral hepatitis
- (2010) Ivan Gentile et al. JOURNAL OF HEPATOLOGY
- Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy
- (2010) Christian Markus Lange et al. JOURNAL OF HEPATOLOGY
- Homocysteine levels and sustained virological response to pegylated-interferon α2b plus ribavirin therapy for chronic hepatitis C: a prospective study
- (2010) Guglielmo Borgia et al. LIVER INTERNATIONAL
- Telaprevir: A Promising Protease Inhibitor for the Treatment of Hepatitis C Virus Infection
- (2009) I. Gentile et al. CURRENT MEDICINAL CHEMISTRY
- The efficacy and safety of telaprevir – a new protease inhibitor against hepatitis C virus
- (2009) Ivan Gentile et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression
- (2009) Gary L. Davis et al. GASTROENTEROLOGY
- Iron depletion before HCV antiviral therapy: A pilot, randomized, controlled trial
- (2009) Ivan Gentile et al. JOURNAL OF CLINICAL APHERESIS
- Disease Progression in Chronic Hepatitis C: Modifiable and Nonmodifiable Factors
- (2008) Sharif B. Missiha et al. GASTROENTEROLOGY
- Diagnosis, management, and treatment of hepatitis C: An update
- (2008) Marc G. Ghany et al. HEPATOLOGY
- A Simple Noninvasive Score Predicts Gastroesophageal Varices in Patients With Chronic Viral Hepatitis
- (2008) Ivan Gentile et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Multiple Sclerosis and Hepatitis C Virus Infection Are Associated with Single Nucleotide Polymorphisms in Interferon Pathway Genes
- (2008) Giuliana Fortunato et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now